This report provides: 

• An overview of the global market for digital polymerase chain reaction (PCR) technology.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Discussion of key manufacturers, suppliers, users, and a variety of factors influencing demand.
• Patent analyses.
• Comprehensive company profiles of major players in the market.

This report provides: 

• An overview of the global markets for synthetic biology.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Coverage of core synthetic biology products: synthetic genes, other DNA parts, chassis organisms, synthetic cells.
• Coverage of enabling technologies: DNA sequencing, oligonucleotides, specialty media, bioinformatics.
• Coverage of enabled technologies: biofuels, specialty chemicals, diagnostics, pharmaceuticals, agriculture. 
• Analysis of the synthetic biology industry structure, competitors, and intellectual property landscape.
• Assessments of the products and technologies most commercially viable now and in the near future. 
• Company profiles of major players in the market.

This report provides: 

• An overview of the global market for cardiac biomarkers and related technologies.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Classification of cardiac biomarkers by cerebrovascular, congestive, coronary, hypertensive, and peripheral arterial disease.
• Background and clinical values of cardiac biomarkers, including B-type natriuretic peptide (BNP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), C-reactive protein (CRP), choline, creatine kinase MB (CK-MB), D-dimer, glial fibrillary acidic protein (GFAP), heart fatty acid binding protein (H-FABP), ischemia-modified albumin (IMA), myeloperoxidase (MPO), myoglobin, soluble fragment CD40 ligand (sCD40L), and troponin I (cTnI)/troponin T (cTnT).
• Examination of the technology regarding diagnostic methods, instrumentation, newly issued patents, and new patent applications.
• Coverage of clinical guidelines and government regulations.
• Company profiles of major players in the market.

This report provides: 

• An overview of the global markets and expected consumption for immunohistochemistry (IHC) technologies.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Coverage of major trends and challenges that affect the market and the supplier landscape.
• End-use industry coverage, including hospitals and diagnostic laboratories, and research institutes.
• Evaluation of the market's dynamics, including growth drivers and restraints.
• Company profiles of major players in the market.

This report provides: 

• An overview of the global market for polymerase chain reaction (PCR) in point-of-care (POC) diagnostics.
• Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Detailed analysis of point-of-care molecular diagnostics, technological trends, and governmental regulatory policies.
• Examination of various segments of the POC-PCR market, including cyclers, systems, applications, and cartridges.
• Patent analyses.
• Company profiles of major players in the market.

This report provides: 

• An overview of the global market for the neurology products.
• Analyses of global market trends, with data from 2016, estimates for 2017, projections of compound annual growth rates (CAGRs) through 2022.
• An in-depth analysis of new products in the development pipeline, as well as newly-emerging drug-device combinations and stem cell therapies.
• A look in to the manufacturers of urological technologies based on product types, market share, region, and key corporate activities.
• Analysis of the market in terms of the regulatory and reimbursement environment and factors influencing market growth and demand
• Comprehensive company profiles of major players in the industry.

This report provides:

• An overview of the global market and technologies for biological therapies for cancer.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Detailed analyses of products in the market, market structure and competitive environments, cancer markets in newly emerging therapeutics, and analysis of biosimilars and their impact on the market.
• Details concerning the strengths, weaknesses, opportunities, and threats facing various cancer biotherapeutics already on the market.
• A look at major issues involved in the research and development (R&D) of more effective cancer therapeutics, and new cancer therapeutics in development and in clinical trials.
• Profiles of major players in the cancer biotherapeutics field.

This report provides:

• An overview of the global market for biologic therapeutic drugs.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Coverage of large market segments, such as monoclonal antibodies (mAb), therapeutic proteins, and vaccines.
• Examination of the competitive environment, with a special focus on how new products and technologies are influencing the current standards of care.
• Analysis of the market's dynamics, specifically growth drivers, restraints, and opportunities.
• Profiles of current market leaders, as well as companies with innovative products  poised to advance within the forecast period.

This report provides: 

• An overview of the market for companion diagnostics, including existing products on the market and detailed analysis of the competitive environments.
• Analyses of market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023.
• Examination of the current state of the industry, new technologies in assay development, and potential novel commercial venues in this area of the healthcare industry.
• Identification of major commercial sectors in companion diagnostics: oncology related products vs. cardiovascular diseases and other segments.
• Profiles of major players as well as a list of current companies that have new companion diagnostics products in development.

This report provides market size estimates and forecasts for the global market and all major market segments through 2023.

This report provides:

• An overview of the global market for cancer profiling and pathways.
• Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
• Discussion of products in this market, newly emerging tools, diagnostics and therapeutics, and their impacts on the market.
• Examination of evolving methods, such as microarray analysis, multiplex PCR, and quantitative real-time PCR, which are integral to deciphering molecular mechanisms  involved in gene function, biological development, and disease progression, and are important tools in the discovery and development of new drug targets and diagnostic biomarkers.
• Identifications of important cancer profiling techniques, market shares by types of products on the market, and market shares by company, as well as types of cancers and biomarkers.
• Coverage of epigenetic, methylation, and miRNA products in development, products in clinical trials and currently marketed, and clinical-stage development products.
• Company profiles of key players in the market.